| Jun 13, 2013
| 2:54 PM
The U.S. Supreme Court decision that Myriad Genetics cannot patent two genes linked to ovarian and breast cancer came as welcome relief to researchers whose work on BRCA1 and BRCA2 genes had been thwarted by legal challenges from the company.
| Jun 18, 2013
| 8:25 AM
Orestes De La Paz's exhibit at the Frost Art Museum in Miami in May recalled Chuck Palahniuk's novel and film Fight Club, in which lead character Tyler Durden's principal income source was making upscale soap using discarded liposuctioned fat fetched from...
| Aug 28, 2011
| 6:22 PM
NEW YORK (Reuters) - Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer women at high risk for the disease, government researchers said.
Ovarian cancer isn't very common...
| Jul 29, 2011
| 9:59 PM
CHICAGO (Reuters) - A U.S. federal appeals court affirmed the right of Myriad Genetics to patent two genes linked to breast cancer, overturning a lower court ruling that threatened a key element of the biotech business.
The U.S. Court of Appeals for...
| Jan 11, 2010
| 9:32 PM
Genetic research breakthroughs have come to be expected -- greeted with a sense of inevitability and the quiet assurance that science will ultimately puzzle out, then cure, human disease. But how those breakthroughs actually yield benefits is complicated....